atai Life Sciences (ATAI) Tops Q3 EPS by 2c

atai Life Sciences (NASDAQ: ATAI) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $24M .

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Exyn Technologies reports Q1 2026 results after Nasdaq IPO
• Morgan Stanley Resumes Bath & Body Works Inc. (BBWI) at Equalweight